cysteine has been researched along with Fibrosarcoma in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flaherty, NL; Hempel, N; McCarthy, DA; Melendez, JA; Patel, N; Ranganathan, A; Subbaram, S; Trebak, M | 1 |
| Izumi, H; Kaneko, K; Matsumoto, T; Mitomi, H; Okubo, T; Saito, T; Sato, K; Suehara, Y; Takagi, T; Torigoe, T; Yao, T | 1 |
| Cho, JH; Choi, EJ; Huh, SH; Kim, MS; Park, HS; Ryoo, K; Yu, JW | 1 |
| Anton, M; Gansbacher, B; Kopitz, C; Krüger, A | 1 |
| Dohmae, N; Lai, NS; Muroi, M; Osada, H; Simizu, S; Suzuki, T; Takagi, S | 1 |
| Davies, PJ; el Alaoui, S; Gentile, V; Griffin, M; Lawry, J; Mian, S | 1 |
| Cherian, MG; Imura, N; Satoh, M; Shimizu, H | 1 |
| Berke, G; Bockstette, M; Dröge, W; Fiers, W; Gross, A; Hack, V; Kinscherf, R | 1 |
| Alitalo, K; Chilov, D; Jeltsch, M; Joukov, V; Kaukonen, J; Kukk, E; Palotie, A; Taira, S | 1 |
| Dröge, W; Hack, V; Ushmorov, A | 1 |
| Deryugina, EI; Marchenko, GN; Monosov, EZ; Quigley, JP; Ratnikov, BI; Rozanov, DV; Strongin, AY | 1 |
11 other study(ies) available for cysteine and Fibrosarcoma
| Article | Year |
|---|---|
Redox-control of the alarmin, Interleukin-1α.
Topics: Calcium; Calpain; Cell Line, Tumor; Cell Nucleus; Cysteine; E1A-Associated p300 Protein; Fibrosarcoma; HEK293 Cells; Humans; Hydrogen Peroxide; Interleukin-1alpha; NF-kappa B; Oxidation-Reduction; Superoxide Dismutase | 2013 |
A case of secondary malignant giant-cell tumor of bone with p53 mutation after long-term follow-up.
Topics: Adenocarcinoma; Arthrography; Base Sequence; Cell Transformation, Neoplastic; Cysteine; Femur; Fibrosarcoma; Follow-Up Studies; Genes, p53; Genes, Recessive; Giant Cell Tumor of Bone; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Molecular Sequence Data; Mutation; Neoplasm Recurrence, Local; Rectal Neoplasms; Thymine; Tomography, X-Ray Computed; Tumor Suppressor Protein p53 | 2011 |
Inhibition of apoptosis signal-regulating kinase 1 by nitric oxide through a thiol redox mechanism.
Topics: Animals; Cell Line; Cysteine; Enzyme Activation; Enzyme Inhibitors; Fibrosarcoma; Humans; Hydrogen Peroxide; Interferon-gamma; MAP Kinase Kinase Kinase 5; MAP Kinase Kinase Kinases; Mice; Mutagenesis, Site-Directed; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroarginine; Oxidation-Reduction; Penicillamine; Structure-Activity Relationship; Sulfhydryl Compounds; Transfection; Tumor Cells, Cultured | 2004 |
Reduction of experimental human fibrosarcoma lung metastasis in mice by adenovirus-mediated cystatin C overexpression in the host.
Topics: Adenoviridae; Animals; Cathepsins; Cystatin C; Cystatins; Cysteine; Fibrosarcoma; Genetic Therapy; Humans; Lung Neoplasms; Mice | 2005 |
Involvement of disulfide bond formation in the activation of heparanase.
Topics: Amino Acid Sequence; Cell Line, Tumor; Cysteine; Disulfides; Enzyme Activation; Enzyme Inhibitors; Fibrosarcoma; Glucuronidase; Humans; Molecular Sequence Data; Structure-Activity Relationship; Transfection | 2007 |
The importance of the GTP-binding protein tissue transglutaminase in the regulation of cell cycle progression.
Topics: Animals; Binding Sites; Blotting, Western; Cell Cycle; Cell Division; Cricetinae; Cysteine; DNA; Fibrosarcoma; GTP-Binding Proteins; Homeostasis; Humans; Mutagenesis, Site-Directed; Point Mutation; Protein Processing, Post-Translational; Recombinant Proteins; Serine; Transfection; Transglutaminases; Tumor Cells, Cultured | 1995 |
Modulation of resistance to anticancer drugs by inhibition of metallothionein synthesis.
Topics: Alkynes; Animals; Cisplatin; Colonic Neoplasms; Cysteine; Doxorubicin; Drug Resistance; Female; Fibrosarcoma; Glycine; Humans; Male; Melphalan; Metallothionein; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Pargyline; Sulfates; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Zinc Compounds; Zinc Sulfate | 1994 |
Abnormal glutathione and sulfate levels after interleukin 6 treatment and in tumor-induced cachexia.
Topics: Animals; Cachexia; Cysteine; Female; Fibrosarcoma; Glutamate-Cysteine Ligase; Glutathione; Interleukin-6; Liver; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Sulfates; Tumor Cells, Cultured; Urea | 1996 |
Genomic organization of human and mouse genes for vascular endothelial growth factor C.
Topics: Alternative Splicing; Amino Acid Sequence; Animals; Base Sequence; Binding Sites; Cloning, Molecular; Cysteine; DNA Primers; Endothelial Growth Factors; Exons; Fibrosarcoma; Genetic Variation; Genomic Library; Humans; Introns; Mice; Molecular Sequence Data; Multigene Family; Polymerase Chain Reaction; Protein Biosynthesis; Restriction Mapping; Sequence Alignment; Sequence Homology, Nucleic Acid; Transcription Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor C | 1997 |
Differential reconstitution of mitochondrial respiratory chain activity and plasma redox state by cysteine and ornithine in a model of cancer cachexia.
Topics: Acetylcysteine; Adenosine Triphosphate; Animals; Biomarkers; Blood Glucose; Cachexia; Cysteine; Cystine; Electron Transport; Energy Metabolism; Fibrosarcoma; Free Radical Scavengers; Glutathione; Glycolysis; Insulin Resistance; Mice; Mice, Inbred C57BL; Mitochondria; Models, Biological; Muscle, Skeletal; Ornithine; Oxidation-Reduction; Oxidative Phosphorylation; Oxidative Stress; Plasma; Receptor, Insulin; Serum Albumin; Spermine; Sulfhydryl Compounds | 1999 |
Mutation analysis of membrane type-1 matrix metalloproteinase (MT1-MMP). The role of the cytoplasmic tail Cys(574), the active site Glu(240), and furin cleavage motifs in oligomerization, processing, and self-proteolysis of MT1-MMP expressed in breast car
Topics: Breast Neoplasms; Cysteine; Dimerization; Dipeptides; DNA Mutational Analysis; Enzyme Activation; Female; Fibrosarcoma; Glutamine; Humans; Hydroxamic Acids; Indoles; Matrix Metalloproteinases, Membrane-Associated; Metalloendopeptidases; Mutagenesis, Site-Directed; Protease Inhibitors; Protein Processing, Post-Translational | 2001 |